Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

While Congress Fiddles, Big Pharma Is in for Big Changes

Efforts to avert an unprecedented economic crisis. Also, expiring patents on prescription drugs will have a major impact on the pharmaceutical industry and US consumers.

  • rss
Download MP3
  • Share
By Warren Olney • Jul 29, 2011 • 50m Listen

The debt limit deadline is Tuesday, and Washington is a weekend away from a spending and deficit bill acceptable to both parties. We update last-minute efforts to avert an unprecedented economic crisis.

Also, a wave of expiring patents on prescription drugs will have a major impact on the pharmaceutical industry and on US consumers. Prices for Lipitor and Plavix alone may drop by 80 percent, great for both employers and workers. But where will the money to invent new medications come from? We hear how the drug industry gets multiple patents on a single drug and "pays for delay" to hold off generic replacements.

Banner image: Pam Harvey fills a prescription at Adams Discount Pharmacy in Glenside, Pennsylvania. Photo by William Thomas Cain/Getty Images

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Warren Olney

    former KCRW broadcaster

    NewsNationalPolitics
Back to To the Point